Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica
Institut
IRB Barcelona - Institute for Research in Biomedicine
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von IRB Barcelona - Institute for Research in Biomedicine (10)
2024
-
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)
Vaccines, Vol. 12, Núm. 1
-
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium (npj Vaccines, (2024), 9, 1, (53), 10.1038/s41541-024-00838-8)
npj Vaccines
-
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium
Emerging Microbes and Infections, Vol. 13, Núm. 1
-
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
npj Vaccines, Vol. 9, Núm. 1
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
2018
-
Identification of New Activators of Mitochondrial Fusion Reveals a Link between Mitochondrial Morphology and Pyrimidine Metabolism
Cell Chemical Biology, Vol. 25, Núm. 3, pp. 268-278.e4
-
PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy
Journal of Controlled Release, Vol. 276, pp. 125-139